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Abstract
Type 3 secretion systems are complex nanomachines used by many Gram–negative bacteria to deliver tens of proteins
(effectors) directly into host cells. Once delivered into host cells, effectors often target to specific cellular loci where they
usurp host cell processes to their advantage. Here, using the yeast model system, we identify the membrane localization
domain (MLD) of IpgB1, a stretch of 20 amino acids enriched for hydrophobic residues essential for the targeting of this
effector to the plasma membrane. Embedded within these residues are ten that define the IpgB1 chaperone-binding
domain for Spa15. As observed with dedicated class IA chaperones that mask hydrophobic MLDs, Spa15, a class IB
chaperone, promotes IpgB1 stability by binding this hydrophobic region. However, despite being stable, an IpgB1 allele that
lacks the MLD is not recognized as a secreted substrate. Similarly, deletion of the chaperone binding domains of IpgB1 and
three additional Spa15-dependent effectors result in alleles that are no longer recognized as secreted substrates despite the
presence of intact N-terminal secretion signal sequences. This is in contrast with MLD-containing effectors that bind class IA
dedicated chaperones, as deletion of the MLD of these effectors alleviates the chaperone requirement for secretion. These
observations indicate that at least for substrates of class IB chaperones, the chaperone-effector complex plays a major role
in defining type 3 secreted proteins and highlight how a single region of an effector can play important roles both within
prokaryotic and eukaryotic cells.
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Introduction
Modulation of host signaling pathways by bacterial pathogens is
critical as it enables these microorganisms to colonize and replicate
within or in the vicinity of eukaryotic host cells. To facilitate this
goal, bacteria have evolved a variety of mechanisms to deliver
proteins directly into host cells, proteins that act to usurp host cell
processes to promote bacterial survival and spread. For example,
over the course of an infection, Shigella species, the causative agents
of bacillary dysentery, utilize a type 3 secretion system (T3SS) to
directly inject at least 30 proteins, referred to as effectors, into
intestinal epithelial cells (for review see [1]).
A key step in Shigella pathogenesis is the ability of this
intracellular pathogen to mediate its own uptake of into normally
non-phagocytic epithelial cells. Several type 3 secreted effectors
including IpgB1 are involved in this process. IpgB1 is a GEF (GTP
exchange factor) [2] that localizes to host cell membranes at
bacterial entry sites where it activates the small GTPases Rac and
Cdc42 to induce membrane ruffling which promote the uptake of
Shigella into host cells [3–6]. Shigella strains that no longer encode
IpgB1 are impaired in invasion, produce smaller ruffles and are
attenuated in virulence [6].
The translocation (delivery) of IpgB1into host cells is dependent
on Spa15, a class IB type 3 secretion chaperone [7]. In addition to
IpgB1, Spa15 binds to and mediates the secretion of eight
additional Shigella effectors [7–10]. Interestingly, these nine
effectors share a conserved amino acid sequence, the conserved
chaperone binding domain (CCBD) sequence, within their first 50
residues that mediates interactions with Spa15 [11].
In this study, using the yeast Saccharomyces cerevisiae as a model
system [12,13], we have identified a twenty amino acid region of
IpgB1 responsible for its membrane localization. This region, like
that of the previously mapped membrane localization domains
(MLDs) of several other type 3 effectors, is enriched in
hydrophobic residues that likely promote membrane targeting.
Included within these twenty residues are ten that define the IpgB1
chaperone binding domain (CBD) [11]. Interestingly, although
IpgB1 is one of nine effectors that bind Spa15, the stability of only
IpgB1 is dependent on this class IB chaperone. In the absence of
Spa15, IpgB1 stability is restored by the deletion of the twenty
residues that define its MLD. Thus, as previously observed with
other effectors that target host cell membranes, chaperones can act
within bacteria to mask hydrophobic MLDs. However, in contrast
to other MLD-containing effectors, which are secreted in the
absence of their cognate chaperones when their MLDs are deleted,
IpgB1 alleles that lack its MLD or just its CBD are no longer
secreted. Similarly, at least three additional Spa15-dependent
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e93461effectors are also no longer recognized as secreted substrates when
their CBDs are deleted, despite the presence of an intact N-
terminal secretion signal sequence. Thus, our studies demonstrate
how a single region of an effector, in this case IpgB1, can play
important roles both in defining the protein as a bacterial secreted
substrate as well as in promoting membrane localization once
delivered into mammalian cells.
Experimental Procedures
Plasmids and strains
Shigellaeffectors
gene introduced into an entry vector was sequence verified and
subsequently transferred via an LR reaction (Invitrogen) into a
destination expression vector. For expression in yeast, the genes
were introduced into pDYST-GFP-ccdB, a high copy number (2m)
plasmid that carries the LEU2 gene and the GAL10 promoter [15].
For the bacterial expression studies, genes encoding the specified
alleles were introduced into pDSW206-ccdB-FLAG, a low copy
(ColE1 ori) ampicillin resistance plasmid that carries an impaired
pTac promoter [10]. All the Shigella studies were conducted in S.
flexneri 2457T serotype 2a [10]. The spa15 and ipgB1 Shigella
deletion strains were generated using the lred recombination system
[16]. All oligonucleotide used in this study are described in Table S1.
Yeast fluorescence microscopy
600 of 0.5
dehyde, permeabilized with 70% ethanol for 20 min and stained
with DAPI for10 min. Images were captured digitally using a
black-and-white Sensys charge-coupled-device (CCD) camera and
IPLAB software (Scanalytics). Color images were assembled by
separately capturing signals with each of the appropriate filter sets
and digitally pseudocoloring the images. The bars in the images
represent ,2 mm, half the length of a haploid yeast.
Bacterial protein preparations
Wild type and Dspa15 Shigella strains carrying the designated
uC
in TCS (trypticase soy) broth. Cultures were back-diluted 1:100
and grown at 37uC, to allow for expression and assembly of an
600=0.6,expressionof
mM)for30min.
600, were harvested
Secretion assays
Secretion assays were carried as previously described in
and Dspa15 Shigella carrying the designated pDSW206-effector-
FLAG plasmids were back-diluted 1:100 and incubated on a
roller at 37uC until OD600=0.6. IPTG was added to a final
concentration of 100 mM to induce expression of proteins for
30 min. Type 3 secretion was then activated by the Congo red dye
for additional 30 min incubation. The supernatant fraction was
separated by two centrifugations at 20,000 g for 2 min and the
proteins in the supernatant of the second centrifugation were
precipitated with TCA (10%). Protein content of the supernatant
was analyzed by immunoblotting as described above.
Results
The N-terminal 50 Residues of IpgB1 are Sufficient to
Target Proteins to the Yeast Plasma Membrane
The yeast Saccharomyces cerevisiae is an established model system
for studying bacterial virulence proteins, including type 3 secreted
effectors. Many effectors exhibit conserved subcellular localization
patterns as well as activities when expressed in yeast and
mammalian cells [12,17,18]. Interestingly, as shown in Figure 1A
and in earlier published studies from our group [10,11], IpgB1 is
the only one of over 20 Shigella effectors tested that exhibits a
membrane subcellular localization pattern when expressed in
yeast. This localization reflects conserved subcellular targeting, as
IpgB1 localizes to the plasma membrane during the course of an
infection or when transiently expressed de novo in mammalian
cells [6]. Thus, given that the mechanism that mediates IpgB1
membrane localization is presumably conserved from yeast to
humans, we chose to examine this process using the genetically
tractable yeast model system.
First, given that IpgB1 is a GEF for Rac and Cdc42 [2] and that
many yeast and mammalian GEFs and the GTPases that they
bind often localize to membranes, we investigated whether IpgB1
membrane targeting is dependent on its GEF activity. To test this
possibility, we compared the yeast subcellular localization patterns
of GFP-IpgB1 and GFP-IpgB1_E80A, an allele that carries a
mutation in the conserved WxxxE motif. This mutation eliminates
GEF activity and based on the solved structures of close IpgB1
homologs is predicted to disrupt the GEF domain [2,19]. As
shown in Figure 1A, wild type IpgB1 and IpgB_E80A both
localize to the plasma membrane suggesting that IpgB1 GEF
activity does not play a major role in mediating IpgB1 membrane
targeting.
IpgB1 promotes Shigella uptake and membrane ruffling by
recruiting the ELMO-Dock180 complex to membranes [5].
Interestingly, fusion of the first 105 residues of IpgB1 to ELMO
is sufficient to generate a protein that localizes to the plasma
membrane and promotes the formation of membrane ruffles [5].
To test whether this region of IpgB1 encodes a membrane
localization domain, we investigated whether fusion of the first 100
residues of IpgB1 to GFP is sufficient to redirect GFP to the yeast
plasma membrane. However, the fusion protein was unstable
when expressed in yeast and no fluorescent protein was visible
(data not shown). To circumvent this instability issue, we
investigated and developed a complementary reciprocal swap
strategy to identify the region(s) of IpgB1 sufficient to confer
membrane localization to its close structural homolog Shigella
IpgB2.
IpgB2, like IpgB1, is a Rho GEF and a member of the WxxxE
effector family. The predicted secondary structures of IpgB1 and
IpgB2 are essentially identical across their GEF domains [4]. In
addition, within their first ,50 amino acids, residues upstream of
their respective GEF domains, each effector encodes a variant of
the conserved chaperone binding domain sequence, a region that
mediates the binding of each to their shared cognate Shigella
chaperone, Spa15 [11] (Figure 1B). While IpgB1 activates Rac and
Cdc42, IpgB2 is a GEF for RhoA [19]. Differences in specificity
likely explain why expression of IpgB1 mildly impairs yeast
growth, while expression of IpgB2 is highly toxic [14]. Due to this
A Single Region of the T3SS Effector IpgB1 Has Dual Function
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were introduced into pDNR221 via BP reactions (Invitrogen). Each
genes flank by attB sites and an upstream Shine-Dalgarno sequence
site-specific recombination system (Invitrogen). Amplified mutant
effector alleles were generated via overlap PCR and the Gateway
have been previously described [10,11,14].Themutantandchimeric
All of the plasmids encoding wild typeallelesofthe
Schmitz et. al.[10]. Briefly, overnight cultures of wild type
immunoblotting with anti-Flag (Sigma) and anti-IpaB antibodies.
and lysed in SDS-PAGE buffer. Protein content was analyzed by
Equivalent numbers of bacteria, based on OD
the FLAG-tagged effectorswasinducedbyIPTG (100
intact type 3 secretion system.WhenatanOD
pDSW206-effector-FLAG plasmids were grown overnight at 37
Yeast expression plasmids were transformed into S288C using the
PEG/lithium acetate method.Yeastcarryingtheplasmidsweregrown
overnight in SC - Leu media with 2% raffinose as a carbon source.
and incubated for an additional 2 hours (h) at which point galactose
was added (final concentration of 2%). Four hours post–induction,
yeast cells were visualized using a Nikon TE3000 microscope with
Chroma Technology filters and a 100x objective. To visualize nuclei,
yeast cells were harvested, fixed for 30 minutes (min) with paraformal-
In the morning the cultures were back diluted to an ODtoxicity, wild type alleles of IpgB2 fused to GFP are poorly
visualized in yeast [10]. Thus, for the reciprocal swap experiments,
we used a catalytically dead allele of IpgB2 (IpgB2_W62A). This
allele is mutated at the conserved tryptophan of the WxxxE motif
[4] results in loss of GEF activity and completely alleviates yeast
toxicity [10]. GFP-IpgB2_W62A, hereafter referred as IpgB2,
exhibits a nuclear subcellular localization pattern when expressed
in yeast (Figure 1C).
Given that IpgB1 localizes to the plasma membrane indepen-
dently of its GEF activity, we next investigated whether the N-
terminal region of IpgB1 is sufficient to target heterologous
proteins to the plasma membrane. Thus, we swapped the regions
of IpgB1 and IpgB2 predicted to reside upstream of the first a-
helix of their GEF domains, position 47 of IpgB1 and position 50
of IpgB2 [4]. Strikingly, as shown in Figure 1C, the N-terminal
reciprocal swaps resulted in a complete switch in the subcellular
localization patterns of the two chimeric proteins. IpgB1 with the
N-terminal residues of IpgB2 localized to the nucleus, while IpgB2
with the N-terminal residues of IpgB1 localized to the plasma
membrane. Therefore, a region encoded within the first 47
residues of IpgB1 plays a major role in directing the localization of
IpgB1 as well as heterologous proteins to the plasma membrane.
Residues within the Chaperone Binding Domains of
IpgB1 and IpgB2 Play Major Roles in Determining their
Eukaryotic Subcellular Localization Patterns
As outlined in Figure 2A, the N-terminal regions that define the
unique subcellular localization patterns of IpgB1 and IpgB2
encompass each their type 3 secretion signal and chaperone
binding domains sequences [11]. To test whether residues present
to either of these domains of IpgB1 are sufficient to direct
membrane targeting, we generated smaller reciprocal swaps within
the N-terminal residues of the two effectors. First we exchanged a
20 amino acid region that includes the chaperone binding domain
(CBD) of each effector plus its downstream 10 amino acids, the
residues present before the start of the predicted GEF domain of
each. As shown in Fig. 2B (chimeras A and B), the replacement of
the 20 residues of one effector with those from the other resulted in
a complete switch in their subcellular localization patterns, i.e., the
introduction of twenty residues of IpgB1 into IpgB2 resulted in an
allele of IpgB2 that localizes to the plasma membrane.
We then generated smaller reciprocal swaps to investigate
whether the introduction of the ten residues that define the CBD
of IpgB1 is sufficient to direct membrane targeting when
introduced into IpgB2 (chimeras C and D). As shown in
Figure 2B, the presence of just ten residues of IpgB1, specifically
the amino acids that define its CBD [11], is sufficient to generate
an allele of IpgB2 that localizes to the plasma membrane.
Similarly, the introduction of the ten residues that map to the
IpgB2 CBD into IpgB1 resulted in an allele of IpgB1 that localizes
to the nucleus (Figure 2B). Thus, while the conserved CBD
sequences of IpgB1 and IpgB2 perform identical functions within
Shigella, the same residues dictate distinct subcellular localizations
once the proteins are introduced into eukaryotic cells.
The CBD of IpgB1 is Located within a Membrane
Localization Domain
We next investigated whether the ten residues present within the
chaperone binding domain of IpgB1 are necessary to direct its
membrane localization. As shown in Figure 3A, deletion of these
10 residues from intact wild type IpgB1 (IpgB1_D28–37) does not
abrogate IpgB1 membrane localization. However, extension of the
Figure 1. The N-terminal region of IpgB1 is sufficient to target proteins to the yeast plasma membrane. (A, C) Yeast that conditionally
express each of the designated fusion proteins under the control of a GAL1 promoter were visualized by fluorescence microscopy 4 h post-induction
of protein expression. The (-) in panel (A) represents free GFP. (B) Schematic representation of IpgB1 and IpgB2. (C) Yeast were fixed and stained with
DAPI to visualize nuclear DNA. The images shown are representative of at least 3 independent experiments. All of the GFP positive yeast cells
visualized for each condition exhibited the subcellular localization pattern shown.
doi:10.1371/journal.pone.0093461.g001
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38–47 (IpgB1_D28–47) results in an allele that like free GFP
(Figure 1B) localizes diffusely in yeast cells. Thus, we have
identified a region of 20 amino acids required for the membrane
localization of IpgB1.
At least three general mechanisms have been described to
mediate the targeting of bacterial effectors to host cell membranes
(for review, see [20]). First, numerous membrane localized
effectors, including Salmonella SifA, another member of the WxxxE
family of effectors, undergo lipidation modifications post-delivery
into host cells that promote membrane targeting, i.e., palmitoyla-
tion, prenylation, and myristoylation [21,22]. Second, at least in
the case of Salmonella, coiled-coiled domains of multiple effectors
assist in membrane targeting [23]. Lastly, multiple effectors encode
membrane localization domains or MLDS, regions hypothesized
to directly or indirectly promote interactions between effectors and
membranes. MLDs are currently characterized as regions of
effectors enriched in hydrophobic and charged residues that when
deleted result in loss of effector membrane targeting [20,24–27].
No specific sequence is shared.
Bioinformatic based analyses suggest that the residues required
for IpgB1 membrane localization do not undergo any post-
translational lipidation modifications nor encode a coiled-coil
domain. However, similar to the regions of those effectors that
encode MLDs, the region of IpgB1 required for membrane
localization is enriched for hydrophobic as well as charged amino
acids (Figure 3B). MLDs of variable lengths ranging from 20 to 90
residues have been mapped and the deletion of each of these
regions, like residues 28–47 or IpgB1, results in loss of effector
membrane targeting [20,24–26].
Interestingly, the MLDs of Yersinia YopE, Pseudomonas ExoS and
Pseudomonas ExoT share a conserved 22 amino acid symmetrical
leucine-rich motif. In the case of ExoS substitution of the
conserved hydrophobic leucines with polar asparagines disrupts
its membrane localization [26]. While the length of the region of
IpgB1 needed for membrane targeting is similar to ExoS, ExoT
and YopE, the spacing of the leucines in the membrane targeting
region of IpgB1 differs. Nevertheless, to test whether hydrophobic
interactions also likely play a role in IpgB1 membrane targeting,
we converted each of the leucines residues present within IpgB1
between amino acid 28 and 47 to asparagines. As observed with
ExoS, when all three leucines are altered, IpgB1 no longer exhibits
a membrane localization pattern (Figure 3C). Notably, all three
leucines needed to be mutated, as the conversion of only leucines
28 and 33 to asparagines does not impair IpgB1membrane
localization pattern of IpgB1 (Figure 3C). Therefore, comparable
to ExoS, ExoT and YopE, the hydrophobic residues of the IpgB1
likely drive effector membrane targeting. Thus, we propose that
this 20 amino acid region of IpgB1 also defines an MLD.
Spa15 Promotes IpgB1 Stability by Masking Hydrophobic
Residues within the MLD
Similar to IpgB1, the membrane localization domains of Yersinia
YopO (YpkA), YopT and YopE overlap with their chaperone
Figure 2. The CBD sequences of IpgB1 and IpgB2 determine their subcellular localization patterns in yeast cells. (A) Schematic
representation of the domains located within the N-terminal regions of IpgB1 and IpgB2. (B) Yeast expressing the designated IpgB1 and IpgB2
chimeras were visualized by fluorescence microscopy 4 h post-induction of protein expression. The images shown are representative of at least 3
independent experiments. All of the GFP positive yeast cells visualized for each condition exhibited the subcellular localization pattern shown.
doi:10.1371/journal.pone.0093461.g002
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phobic residues within MLDs and their propensity to be
positioned within chaperone binding domains, Letzelter and
colleagues proposed that the major role of chaperones is to mask
hydrophobic MLDs to ensure that effectors remain soluble and
stable within bacteria prior to their delivery via the secretion
apparatus into host cells. Consistent with this hypothesis, YopO,
YopT and YopE are unstable when heterologously expressed in E.
coli in the absence of their cognate chaperones [28]. Furthermore,
deletion of the hydrophobic MLD of YopO results in a stably
expressed allele [28]. We next investigated whether this was the
case for IpgB1 and its cognate chaperone, Spa15.
All of the effectors previously identified to contain a MLD bind
class IA chaperones that are dedicated solely to their delivery into
host cells. In contrast, IpgB1 is one of nine effectors that bind
Spa15, a class IB chaperone [3,7,10]. Each of these nine Spa15-
dependent effectors (OspB, OspC1, OspC2, OspC3, OspD1,
OspD2, IpaA, IpgB1 and IpgB2) encodes a variant of the
conserved chaperone binding domain (CCBD) sequence within
its first 50 amino acids. Interestingly although residues within the
CCBD sequence of IpgB1 are important for its membrane
localization, none of the other eight Spa15-dependent effectors
exhibits a membrane localization pattern when expressed in yeast
[10,11].
Previous studies have reported that in Shigella the stability of
IpgB1, but not IpgB2, is dependent on Spa15 [3], suggesting that
Spa15 may not generally act to maintain effector stability. To
investigate this possibility, we compared the relative amount of
each of the nine Spa15-dependent effectors when expressed in wild
type and Dspa15 Shigella. As shown in Figure 4A, steady-state levels
of only IpgB1 is dependent on Spa15. As observed with YopO,
deletion of the MLD of IpgB1 (IpgB1DMLD) restores protein
stability even in the absence of Spa15 (Figure 4B). Thus, while
Spa15 promotes IpgB1 stability by masking its hydrophobic MLD,
the eight other Spa15-depenent effectors do not require Spa15 to
maintain stability. These observations suggest that while a major
function of dedicated class IA chaperones may be to promote
stability of MLD-containing effectors, this is not the case for class
IB chaperones like Spa15.
The CBD Sequence of Spa15-dependent Effectors Is
Necessary to Define these Proteins as Type 3 Secreted
Substrates
Type 3 secretion chaperones have long been recognized to
promote the delivery of effectors into host cells. However, in 2006,
Letzelter and colleagues demonstrated that, at least for Yesinia,
YopO deletion of the MLD results in a stable effector that is
secreted in a chaperone-independent manner. This suggested that,
in the context of MLD-containing effectors, chaperones act to
promote effector stability but do not play a role in the recognition
of the effector as a type three substrate [28]. We next investigated
whether this is generally true and tested whether this is the case for
IpgB1. Notably, as shown in Figure 5A, although IpgB1_DMLD is
stable in both wild type and Dspa15 Shigella (Figure 4B),
IpgB1DMLD is not recognized as a type 3 secreted substrate.
Thus, at least for IpgB1 interactions with its cognate chaperone
are required both to mask its hydrophobic MLD to promote
stability and for its recognition as a T3SS secreted substrate.
Given that the CBD of IpgB1 is embedded within its MLD, we
hypothesized that IpgB1DMLD is not secreted due to the absence
of the CBD. Indeed, as shown in Figure 5B, while deletion of the
ten residues of the CBD is sufficient to partially restore IpgB1
stability in the absence of Spa15, this allele, like IpgB1DMLD, is
not recognized as a secreted substrate either in the presence or
absence of Spa15. Similarly, we observe that deletion of the CBD
of additional three Spa15-dependent effectors, IpgB2, OspB and
OspD1, also results in stable alleles that are not recognized as type
3 secreted substrates (Figure 5C). With the exception of the
deleted 10 residues that define each of their CBDs, the sequence of
all four effectors is unaltered, including the N-terminal residues
that encode their type 3 secretion signal sequences. Thus, in the
case of Shigella class IB Spa15-dependent effectors, the N-terminal
secretion signal sequence seems to not be sufficient to define these
proteins as secreted substrates, rather the CBD or the chaperone-
Figure 3. The chaperone binding domain of IpgB1 is located within its membrane localization domain. (A, C) Yeast expressing the
designated IpgB1 alleles were visualized by fluorescence microscopy 4 h post-induction of protein expression. The images shown are representative
of at least 3 independent experiments. All of the GFP positive yeast cells visualized for each condition exhibited the subcellular localization pattern
shown. (B) Schematic representation of the IpgB1 MLD sequence. The hydrophobic leucines that were replaced by asparagines are indicated in bold.
doi:10.1371/journal.pone.0093461.g003
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Spa15 dependent effectors by the Shigella type 3 secretion
apparatus.
Discussion
Type 3 secreted effectors are multi-domain proteins optimized
not only to be recognized as bacterial secreted substrates, but also
to act within eukaryotic host cells. Generally, the N-terminal
residues of effectors are devoted to protein delivery, while the
downstream residues encode domains that target eukaryotic host
cell proteins. However, there are increasing examples of how these
two regions can overlap. For example, here we demonstrate that a
single region of IpgB1 is essential both for its secretion from
bacteria as well as its targeting to eukaryotic plasma membranes.
IpgB1 is one of ,30 Shigella secreted effectors that are delivered
into host cells during the course of an infection. Notably, of the 22
who have been studied as N-terminal GFP fusion proteins in yeast,
IpgB1 is the only one that exhibits a membrane localization
pattern [10,11]. Interestingly, IpgB1 is a RhoGEF involved in the
formation of the membrane ruffles that engulf and mediate uptake
of these intracellular pathogens into host cells [3–6]. Thus, the
efficient recruitment of IpgB1 to host cell membranes after the
bacteria dock onto host cells presumably plays an important role in
mediating invasion of Shigella into normally non-phagocytic
intestinal epithelial cells [6].
Here, using the yeast model system, we have identified a region
of twenty residues of IpgB1 that defines a membrane localization
domain (MLD). Multiple effectors have now been identified to
encode MLDs. While the domains of three, Pseudomonas ExoS,
ExoT and Yersinia YopE, share a high degree of homology, MLDs
can vary in terms of length and spacing of hydrophobic residues
(for review see [20]). Interestingly, the MLDs of ExoS, ExoT and
YopE are similar in length to that of IpgB1. However, while the
hydrophobic residues of their MLDs are spaced such that they
theoretically lie on the same face of an a-helix [29], this is not the
case for IpgB1. It is unclear whether the MLDs directly bind
membranes or membrane associated proteins. However, in the
case of IpgB1, if the MLD promotes targeting by directly binding
to a host cell protein, this protein or a close homology would need
to be a conserved from yeast to mammals.
IpgB1 is one of nine Shigella effectors that bind Spa15, a class IB
chaperone. Within their N-terminal 50 residues, each of these
effectors encodes a variant of the conserved chaperone binding
domain (CCBD) sequence [11]. The most highly conserved
residues in this consensus sequence [11], those at positions 1, 4 and
7, are hydrophobic in character, yet IpgB1 is the only one of the
nine effectors that exhibits a membrane localization pattern when
expressed in yeast. Notably, a comparison of the overall character
of the residues of the nine Spa15-dependent effectors that
encompass the CCBD plus the downstream ten residues, the
region required for the membrane localization of IpgB1,
demonstrates that the overall hydrophobicity of IpgB1 is greater
than any other effector, again supporting the hypothesis that this
region of IpgB1 drives membrane targeting.
The overlapping of the membrane localization and chaperone
binding domains of IpgB1 and multiple other effectors is perhaps
not that surprising. First, as exemplified by the conserved residues
of the CCBD sequence and observed in chaperone-effector co-
crystal structures, hydrophobic interactions play major roles in
mediating chaperone-effector binding interactions [30,31]. Fur-
thermore, for multiple MLD-containing effectors, including
IpgB1, cognate chaperones promote effector stability within
bacteria by masking the hydrophobic residues. These observations
led Letzelter and colleagues to propose that a major role of
chaperones, at least for MLD-containing effectors, is to promote
Figure 4. Spa15 masks the MLD of IpgB1 to promote effector stability. (A, B) Wild type and Dspa15 S. flexneri strains that conditionally
express the designated FLAG epitope-tagged alleles of each of the 9 Spa15-dependent effectors were grown at 37uCt oa nO D 600=0.4 to induce
expression of the Shigella T3SS. Subsequently, 30 minutes post-induction of the FLAG-tagged effectors, an equal amount of bacteria expressing each
protein were pelleted and lysed. Protein lysates were separated by SDS-PAGE and immunoblotted with anti-FLAG and anti-IpaB antibodies. The latter
serves as a control for loading and for induction of expression of the type 3 secretion apparatus. The blots shown are representative of at least 3
independent experiments.
doi:10.1371/journal.pone.0093461.g004
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chaperone-effector complex to the secretion apparatus [28]. While
this may prove to be the case for class IA chaperones that mediate
the play a role in the secretion of only 1–2 effectors, this does not
appear to be the case with Spa15, a class IB chaperone, which
mediates the secretion of multiple effectors, including IpgB1 into
host cells. Rather our data supports the hypothesis that the
chaperone-effector complex plays a major role in identifying
proteins as secreted substrates [30,32], given that deletion of the
ten residues corresponding to the CCBD sequence of at least four
Spa15-dependent effectors results in loss of their secretion despite
the presence of an intact N-terminal secretion sequence.
Lastly, it is interesting to speculate that Spa15 might have
originally been devoted to the delivery of IpgB1 into host cells.
Spa15 is a class IB type 3 secretion chaperone. In contrast to class
IA chaperones that are encoded within operons alongside their
cognate 1–2 effectors, the gene encoding Spa15 is located adjacent
to those for components of the secretion apparatus. Interestingly,
genes for only two effectors that bind Spa15, IpgB1 and IpaA, are
encoded in close proximity to that which encodes Spa15. And, of
these two, there is evidence that IpaA is secreted via both
chaperone-dependent and chaperone-independent pathways [7].
Furthermore, IpgB1 is the only one of the 9 Spa15-dependent
effectors that doesn’t directly interact with class IB chaperones
from related bacteria that also bind to CCBD sequence containing
effectors [11]. Thus, given that chaperones can play a role in
determining the hierarchy of delivery of effectors into host cells, if
Spa15 binds with highest affinity to IpgB1 perhaps this interaction
ensures that this effector, which plays a major role in host cell
invasion, is one of the first to be delivery into host cells.
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Figure 5. The CBDs of Spa15-dependent effectors are essential for their recognition as secreted substrates. (A, B, C) To assess levels of
secreted effectors, wild type and Dspa15 Shigella strains that conditionally express epitope-tagged alleles of the designated effectors were grown at
37uC to induce expression of the type 3 secretion apparatus. Thirty minutes post-addition of Congo red to induce type 3 secretion, culture
supernatant proteins were TCA precipitated and separated by SDS/PAGE. (B, C) To assess intrabacterial levels of effectors, wild type and Dspa15
Shigella strains that conditionally express the designated FLAG epitope-tagged alleles were grown at 37uCt oa nO D 600=0.4. Subsequently,
30 minutes post-induction of expression of the designated FLAG-tagged effectors, equal numbers of bacteria expressing each effector were pelleted
and lysed. Protein lysates were separated by SDS-PAGE. To determine levels of secreted and intrabacterial effectors, the SDS/PAGE gels were
immunoblotted with anti-FLAG and anti-IpaB antibodies. Anti-FLAG antibody was used to assess effector secretion while anti-IpaB antibody was used
as a control for loading and for induction of expression of the type 3 secretion apparatus. The blots shown are representative of at least 3
independent experiments.
doi:10.1371/journal.pone.0093461.g005
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